Study Stopped
Inadequate funding to support this fellow-in-training initiated study.
The Effects of Probiotics in Atopic Dermatitis
Probiotics Ameliorate Atopic Dermatitis by Induction of T Regulatory Cells
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of this study is to study the clinical effects of taking probiotics in patients who have moderate to severe atopic dermatitis. There has been several studies showing improvement in the severity of atopic dermatitis after taking probiotics. The mechanism of this improvement is currently unknown. We propose that probiotics improve atopic dermatitis by stimulating, or increasing, the activity of a special type of cell called the T Regulatory cell--which can suppress the activity of allergic disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2006
CompletedFirst Posted
Study publicly available on registry
September 19, 2006
CompletedStudy Start
First participant enrolled
July 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2008
CompletedMarch 16, 2016
March 1, 2016
11 months
September 18, 2006
March 14, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
SCORAD Score change taken at baseline and after 1 month of either probiotic or placebo
T Regulatory cell activity change taken at baseline and after 1 month of either probiotic or placebo
Secondary Outcomes (3)
Dermatitis Family Impact Questionnaire change taken at baseline and after 1 month of either probiotic or placebo
T Regulatory cell activity when exposed to probiotics in vitro
Change in Serum IgE or IgG levels taken at baseline and after 1 month of either probiotic or placebo
Interventions
Eligibility Criteria
You may qualify if:
- Age between 6 months to 3 years
- Physician diagnosis of moderate to severe atopic dermatitis as defined by the Hanifin and Rajka criteria
- Ability to take enterally commercially available probiotics by powder form added to food or drink
- Ability to undergo venipuncture or dermal puncture (if less than 1 year old)
You may not qualify if:
- Prior exposure to probiotics
- Current antibiotic administration
- Known history of chronic medical condition such as congenital heart disease, liver or kidney disease, or immune deficiency
- Absence of T regulatory cell induction by probiotic bacteria on initial laboratory assessment
- Any other condition in which the Investigators involved in the study determine potential subject is unsuitable for the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, Los Angeleslead
- Thrasher Research Fundcollaborator
Study Sites (1)
UCLA Medical Center
Los Angeles, California, 90095, United States
Related Publications (8)
Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001 Apr 7;357(9262):1076-9. doi: 10.1016/S0140-6736(00)04259-8.
PMID: 11297958BACKGROUNDIsolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy. 2000 Nov;30(11):1604-10. doi: 10.1046/j.1365-2222.2000.00943.x.
PMID: 11069570BACKGROUNDPessi T, Sutas Y, Hurme M, Isolauri E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy. 2000 Dec;30(12):1804-8. doi: 10.1046/j.1365-2222.2000.00948.x.
PMID: 11122221BACKGROUNDKalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet. 2003 May 31;361(9372):1869-71. doi: 10.1016/S0140-6736(03)13490-3.
PMID: 12788576BACKGROUNDRosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen DL, Valerius NH, Paerregaard A. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol. 2003 Feb;111(2):389-95. doi: 10.1067/mai.2003.389.
PMID: 12589361BACKGROUNDWeston S, Halbert A, Richmond P, Prescott SL. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child. 2005 Sep;90(9):892-7. doi: 10.1136/adc.2004.060673. Epub 2005 Apr 29.
PMID: 15863468BACKGROUNDViljanen M, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy. 2005 Apr;60(4):494-500. doi: 10.1111/j.1398-9995.2004.00514.x.
PMID: 15727582BACKGROUNDSmits HH, Engering A, van der Kleij D, de Jong EC, Schipper K, van Capel TM, Zaat BA, Yazdanbakhsh M, Wierenga EA, van Kooyk Y, Kapsenberg ML. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol. 2005 Jun;115(6):1260-7. doi: 10.1016/j.jaci.2005.03.036.
PMID: 15940144BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael H Land, MD
University of California, Los Angeles
- PRINCIPAL INVESTIGATOR
Martin G Martin, MD, MPP
University of California, Los Angeles
- PRINCIPAL INVESTIGATOR
Robert L Roberts, MD, PhD
University of California, Los Angeles
- STUDY DIRECTOR
Tatiana Hernandez
University of California, Los Angeles
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 18, 2006
First Posted
September 19, 2006
Study Start
July 1, 2007
Primary Completion
June 1, 2008
Study Completion
June 1, 2008
Last Updated
March 16, 2016
Record last verified: 2016-03